1. Home
  2. AGEN vs SUNS Comparison

AGEN vs SUNS Comparison

Compare AGEN & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.23

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.18

Market Cap

124.1M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGEN
SUNS
Founded
1994
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
124.1M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
AGEN
SUNS
Price
$3.23
$9.18
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$14.50
$13.00
AVG Volume (30 Days)
901.2K
140.5K
Earning Date
03-10-2026
03-05-2026
Dividend Yield
N/A
13.04%
EPS Growth
N/A
1112.46
EPS
N/A
1.09
Revenue
$106,829,000.00
$19,384,703.00
Revenue This Year
$23.68
$175.51
Revenue Next Year
$23.17
$63.46
P/E Ratio
N/A
$8.43
Revenue Growth
N/A
2540.16
52 Week Low
$1.38
$7.80
52 Week High
$7.34
$12.43

Technical Indicators

Market Signals
Indicator
AGEN
SUNS
Relative Strength Index (RSI) 40.39 41.76
Support Level $3.12 $9.00
Resistance Level $3.55 $9.35
Average True Range (ATR) 0.38 0.22
MACD -0.04 -0.01
Stochastic Oscillator 6.57 24.69

Price Performance

Historical Comparison
AGEN
SUNS

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

Share on Social Networks: